Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Paul Sherrington
Association of Minimal Residual Disease With Superior Survival Outcomes in Patients With Multiple Myeloma
JAMA Oncology
Cancer Research
Oncology
Related publications
Minimal Residual Disease Assessment in the Context of Multiple Myeloma Treatment
Current Hematologic Malignancy Reports
Cancer Research
Oncology
Hematology
Minimal Residual Disease Testing After Stem Cell Transplantation for Multiple Myeloma
Bone Marrow Transplantation
Transplantation
Hematology
Ficolled Bone Marrow Is Superior to Bone Marrow Buffy Coat for Detection of Minimal Residual Disease in Multiple Myeloma
Hematology
Hematology
Residual Serum Monoclonal Protein Predicts Progression-Free Survival in Patients With Previously Untreated Multiple Myeloma
Cancer
Cancer Research
Oncology
Flow Cytometry in the Diagnosis and Monitoring of Minimal Residual Disease in Multiple Myeloma
Oncogematologiya
Oncology
Hematology
Serological Normalisation as a Surrogate Marker for Minimal Residual Disease Negativity in Multiple Myeloma
British Journal of Haematology
Hematology
Is This the Time to Introduce Minimal Residual Disease in Multiple Myeloma Clinical Practice?
Clinical Cancer Research
Cancer Research
Oncology
Immunoglobulin Heavy/Light Chain Ratios Improve Paraprotein Detection and Monitoring, Identify Residual Disease and Correlate With Survival in Multiple Myeloma Patients
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Minimal Residual Disease Assessment in Multiple Myeloma: Utility and Feasibility in Resource Constraint Settings of India
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
